Synova to market ovulation test:
This article was originally published in Clinica
Executive Summary
Media, Pennsylvania-based provider of noninvasive diagnostic tests Synova Healthcare has gained exclusive North American distribution rights for an ovulation test designed to track a woman's ovulation cycle and, thereby, increase the likelihood of her becoming pregnant. Unlike conventional ovulation kits that use urine samples, this test, developed by Ovulation Tester, uses saliva as a testing medium. The product is already cleared by the FDA and is pending Canadian approval.